Cargando…
Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
Polyglutamine (polyQ) expansion mutation causes conformational, neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These diseases are characterized by the aggregation of misfolded proteins, such as amyloid fibrils, which are toxic to cells. Amyloid fibrils are formed...
Autores principales: | Sugaya, Keizo, Matsubara, Shiro, Kagamihara, Yasuhiro, Kawata, Akihiro, Hayashi, Hideaki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914377/ https://www.ncbi.nlm.nih.gov/pubmed/17653262 http://dx.doi.org/10.1371/journal.pone.0000635 |
Ejemplares similares
-
Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
por: Sugaya, Keizo, et al.
Publicado: (2009) -
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012) -
Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
por: Daldin, Manuel, et al.
Publicado: (2017) -
Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
por: Rose, Claudia, et al.
Publicado: (2010) -
Monomeric, Oligomeric and Polymeric Proteins in Huntington Disease and Other Diseases of Polyglutamine Expansion
por: Hoffner, Guylaine, et al.
Publicado: (2014)